Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Nautilus Biotechnology (NAUT)

Annual Return

Over the past 3 years, NAUT has had an average annual return of -2.46%, underperforming the benchmark SPY, which returned +22.45% annual.

Since Jun 10, 2021, NAUT has had an average annual return of -25.25%, underperforming the benchmark SPY, which returned +13.83% annual.

202620252024202320222021
+32.26%+16.11%-43.82%+66.14%-65.26%-52.91%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+0%+24.08%+60.32%-32.21%+4.18%-5.86%+32.26%
2025+1.83%-23.99%-33.76%-20.05%+8.47%-2.95%+4.86%-10.56%+24.27%+57.42%+69.15%-13.30%+16.11%
2024-7.03%-3.24%+9.33%-13.62%+7.88%-14.61%+15.84%-4.06%+9.60%-8.76%-13.87%-25.00%-43.82%
2023+8.92%+8.14%+30.67%-6.87%+10.87%+35.31%-14.98%-1.84%-2.15%-19.00%+7.43%+8.72%+66.14%
2022-24.32%+2.02%+8.50%+7.60%-21.63%-26.51%+8.18%-24.05%-4.08%+16.50%-26.73%-0.55%-65.26%
2021-8.18%-22.38%+0.65%-22.18%-13.02%-9.19%+6.80%-52.91%

Drawdown analysis of Nautilus Biotechnology (NAUT)

The maximum drawdown for the NAUT was -94.19%, occurring on Sep 3, 2025. This drawdown has not yet recovered.

The current NAUT drawdown is -76.55%.

Since Jun 10, 2021 NAUT has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-94.19%Jun 10, 20211062Sep 3, 2025OngoingOngoingOngoing